Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://fraserezet283628.blogsvila.com/39294776/trelaglutide-exploring-a-new-treatment-for-chronic-diseases